Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Modern Diagnostic & Research Centre Net Margin %?
Modern Diagnostic & Research CentreBOM:544673 15 Net Margin % is 5.22% as of Mar. 2026, which is 30% below its 10-year median of 7.48. GuruFocus rates BOM:544673 with a GF Score™ of 15/100. The stock has 7 warning signs investors should review. Among 202 Medical Diagnostics & Research companies, Modern Diagnostic & Research Centre ranks better than 65.35% on this metric.
BOM:544673'
s Net Margin % Range Over the Past 10 Years
Min: -10.18 Med: 7.48 Max: 11.56
Current: 5.22
BOM:544673's Net Margin % is ranked better than 65.35% of 202
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.75
vs BOM:544673: 5.22
Modern Diagnostic & Research Centre (BOM:544673) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Modern Diagnostic & Research Centre Net Margin % Related Terms
Modern Diagnostic & Research Centre Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modern Diagnostic & Research Centre Net Margin % Chart
Modern Diagnostic & Research Centre Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
Net Margin %
-10.18
8.63
11.56
6.32
Modern Diagnostic & Research Centre Semi-Annual Data
Mar23
Mar24
Mar25
Mar26
Net Margin %
0.00
0.00
0.00
5.22
BOM:544673 vs TMO, DHR, IDXX: Net Margin % Comparison
For the Diagnostics & Research subindustry, Modern Diagnostic & Research Centre's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Modern Diagnostic & Research Centre Net Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Modern Diagnostic & Research Centre's Net Margin % distribution charts can be found below:
* The bar in red indicates where Modern Diagnostic & Research Centre's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Modern Diagnostic & Research Centre (BOM:544673) has a Net Margin % of 5.22% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Modern Diagnostic & Research Centre and its competitors. This is 30% below median its historical median of 7.48. According to the industry distribution chart, Modern Diagnostic & Research Centre ranks #70 out of 202 companies in the Medical Diagnostics & Research industry, placing it in the top 34.7%.
Is Modern Diagnostic & Research Centre's Net Margin % too high?
Modern Diagnostic & Research Centre's current Net Margin % of 5.22% is 30% below median its 10-year median of 7.48. Based on the distribution chart, Modern Diagnostic & Research Centre ranks #70 out of 202 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Modern Diagnostic & Research Centre has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Modern Diagnostic & Research Centre's Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Modern Diagnostic & Research Centre ranks #70 out of 202 companies for Net Margin %. This puts Modern Diagnostic & Research Centre in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Modern Diagnostic & Research Centre and its competitors. Modern Diagnostic & Research Centre's current Net Margin % is 5.22%, which is 30% below median its own 10-year median of 7.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Modern Diagnostic & Research Centre stock overvalued right now?
Modern Diagnostic & Research Centre (BOM:544673) has a current Net Margin % of 5.22%. The current Net Margin % is 5.22%, which is 30% below median its 10-year median of 7.48. Modern Diagnostic & Research Centre's overall GF Score™ is 15/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Modern Diagnostic & Research Centre (BOM:544673), the current Net Margin % is 5.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Modern Diagnostic & Research Centre Ltd is a services provider in diagnostic and related healthcare tests services in India. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory. Through Its integrated, nationwide network, it offers a complete range of diagnostic facilities in radiology and pathology. The company provides healthcare tests and services for use in core testing, patients' diagnosis and prevention, monitoring of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
15GF Score
Get the complete analysis for BOM:544673
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544673 has been successfully added to your 
